{"schema_version":"1","generated_at":"2026-11-04T20:47:41.565Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mudasar-hassan","json_url":"https://www.findmykol.com/kol/mudasar-hassan/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mudasar-hassan","name":"Mudasar Hassan","credential":"MD","specialty":"Psychiatry","specialty_raw":"Psychiatry","therapeutic_area":"Psychiatry","therapeutic_areas":["Psychiatry"],"city":"Brooklyn","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1093202285","openalex":"A5085877355"},"summary":"Mudasar Hassan is a Psychiatry physician. OpenAlex indexes 10 publications with 378 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Psychiatry"]},"scholarship":{"works_count":10,"cited_by_count":378,"h_index":6,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Imbrium Therapeutics","program_year":2025,"amount_usd":102419.13,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093202285"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":48.76,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093202285"},{"payer":"Axsome Therapeutics, Inc.","program_year":2025,"amount_usd":17.97,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1093202285"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1093202285","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Nervous system","share_pct":100,"classes_total":9,"classes":[{"class":"SSRI","setting":"prescribed","share_pct":48.9,"drugs":[{"name":"Trazodone Hcl","share_pct":50.2},{"name":"Sertraline Hcl","share_pct":38.7},{"name":"Escitalopram Oxalate","share_pct":11.1}],"max_beneficiaries":42},{"class":"SNRI","setting":"prescribed","share_pct":12.8,"drugs":[{"name":"Duloxetine Hcl","share_pct":71.9},{"name":"Venlafaxine Hcl Er","share_pct":28.1}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":10,"shown":5,"withheld":5,"matched_by":"OpenAlex author record","recent":[{"title":"Prevalence of Substance use disorder among young adults hospitalized in the US hospital: A decade of change","year":2022,"journal":"Psychiatry Research","source_url":"https://doi.org/10.1016/j.psychres.2022.114913","status":"verified"},{"title":"TARGET JNL: Neuropsychiatric Disease and Treatment Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D Report","year":2021,"journal":"Neuropsychiatric Disease and Treatment","source_url":"https://doi.org/10.2147/ndt.s305331","status":"verified"},{"title":"Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment)","year":2019,"journal":"Journal of Alzheimer s Disease","source_url":"https://doi.org/10.3233/jad-180341","status":"verified"},{"title":"F3‐03‐02: EFFECTS OF A COMPREHENSIVE, INDIVIDUALIZED, PERSON‐CENTERED MANAGEMENT (CI‐PCM) PROGRAM ON ANXIOLYTIC MEDICATION USAGE IN PERSONS WITH MODERATE‐TO‐SEVERE ALZHEIMER'S DISEASE","year":2018,"journal":"Alzheimer s & Dementia","source_url":"https://doi.org/10.1016/j.jalz.2018.06.2749","status":"verified"},{"title":"Traumatic Brain Injury and Neuropsychiatric Complications","year":2017,"journal":"Indian Journal of Psychological Medicine","source_url":"https://doi.org/10.4103/0253-7176.203129","status":"verified"}],"source":"works"},"contact":{"address_1":"76 BELMONT AVE","city":"Brooklyn","state":"NY","zip":"112126719","phone":"718-395-6444","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1093202285","source":"identity"},"similar":[{"name":"Charles Nemeroff","slug":"charles-nemeroff","institution":"Dell Medical School","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/charles-nemeroff","json_url":"https://www.findmykol.com/kol/charles-nemeroff/profile.json"},{"name":"Dennis Charney","slug":"dennis-charney","institution":"Icahn School of Medicine at Mount Sinai","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/dennis-charney","json_url":"https://www.findmykol.com/kol/dennis-charney/profile.json"},{"name":"Maurizio Fava","slug":"maurizio-fava","institution":"Massachusetts General Hospital","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/maurizio-fava","json_url":"https://www.findmykol.com/kol/maurizio-fava/profile.json"},{"name":"John Krystal","slug":"john-krystal","institution":"Yale University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/john-krystal","json_url":"https://www.findmykol.com/kol/john-krystal/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":5}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-10-21","provider_certified":"2025-10-21","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}